VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$18.52
+0.08 (+0.43%)
As of Sep 27, 10:39 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +87.6% upside
Low Target $25.90
Average Target $34.74
High Target $38.60
Current Price $18.52
Current
$18.52
Target
$34.74
$25.90 $34.74 avg $38.60
Scenario Analysis
Bear Case
$25.90
39.8%
Low target
Base Case
$34.74
+87.6%
Avg target
Bull Case
$38.60
+108.4%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$49.95
-62.9% from high
52-Week Low
$6.50
+184.9% from low
Target vs 52W High
$34.74
-30.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%